Priority to be given to 'Corona Warriors' in recruitment of nurses: Himachal CM Sukhu
Shimla: Himachal Pradesh Chief Minister
Sukhwinder Singh Sukhu
interacted with faculty members of
IGMC Shimla
and Atal Institute of Medical Super Specialty, Chamiyana here on Monday evening and discussed in detail the challenges of the future in the health sector.
He said that priority will be given to the nurses who worked during the Corona epidemic in the recruitment of nurses, according to an official release.
CM Sukhu said, "The state government is trying to fill various vacant posts in the health department along-with the use of modern technology.
The posts of doctors are being filled up on priority and priority will be given to the nurses who worked during the Corona epidemic in the recruitment of nurses. He said that along with para-medical staff, technicians are also being recruited. "
"We are ensuring doctor-patient and nurse-patient ratio as per international standards so that they can get a better environment for work", added the Chief Minister.
The heads of departments of various medical colleges made their presentation and the Chief Minister assured that the state government will provide all possible assistance as per the requirements of each medical college.
The Chief Minister said that within a year, machines and equipment older than 20 years in government health institutions will be replaced. The
robotic surgery facility
will be started in Super Specialty Hospital Chamiyana and Tanda Medical College within two months.
Besides, Three Tesla MRI machines are also being installed in all medical colleges in a phased manner, added the release.
He said that the previous governments did not pay any special attention to improving health services, due to which patients are facing various problems.
The present government has given priority to improvement in the field of education and health and Rs 1350 crore are being spent on medical technology.
The state government will provide funds to construct hostels for students studying medicine and parking facility will be strengthened for patients as well as staff.
He said that today the premium health institutions of the state have become mere referral health institutions, hence there is a need for comprehensive improvement in them.
The state government has spent Rs 100 crore for the improvement of health services in IGMC Shimla and in the coming time, Rs 200 crore more will be provided to improve it.
He said that due to restoration of old pension to government employees, many types of financial restrictions have been imposed on Himachal Pradesh, but the state government is still making efforts to improve health services.
He said that patients always come to the hospital with the hope of recovery, in such a situation, if doctors talk to them in a good manner, their suffering will be reduced, added the release.
Health and Family Welfare Minister Colonel (Dr) DhRam Shandil said that such dialogue programmes are important in improving health services. All medical professionals are doing good work in the health institutions of the state and efforts should continue to make it even better.
He said that there is a lot of progress in the field of medical education and the state government is making serious efforts to provide modern machines in Himachal Pradesh so that people can get better health facilities near their homes.
Health Secretary M Sudha Devi gave detailed information about the reforms being done in the health sector by the state government.
Technical Education Minister Rajesh Dharmani, MLA Harish Janartha and other dignitaries were present on this occasion.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Standard
an hour ago
- Business Standard
Onesource Specialty edges higher after inking manufacturing pact with biotech firm Xbrane
Onesource Specialty Pharma advanced 1.55% to Rs 2057 after the company announced a partnership with Sweden-based Xbrane Biopharma AB for manufacturing biosimilars for global markets. Xbrane Biopharma AB is a biotechnology company. It develops biological drugs based on a patented platform technology that provides significantly lower production costs compared to competing systems. Xbrane has a portfolio of biosimilar candidates targeting EUR 23 billion in estimated annual peak sales of the respective reference product. The lead candidate Ximluci (a ranibizumab biosimilar) is granted market authorization approval in Europe (launched in 2023) and is now under the approval process for the U.S. launch. As part of the agreement, Xbrane will tech transfer its select product(s) to OneSources integrated drug substance and drug product (DS/DP) facility in Bangalore, India. The collaboration aims to strengthen Xbranes global supply chain, while enabling OneSource to accelerate regulatory approvals, including from the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA), for its biologics drug substance facility. As part of the collaboration, OneSource has also participated in Xbranes latest funding round, reinforcing the long-term alignment between the two companies. Neeraj Sharma, managing director & CEO of OneSource Specialty Pharma, said: The partnership with Xbrane reflects our shared ambition to drive broader access to cutting-edge biologics worldwide. Xbranes proven success in biosimilar development, combined with OneSources fully integrated biologics platform, creates a strong platform for global impact. We are pleased to support the scale-up of high-quality biosimilars and advance our vision of being a trusted partner to the worlds leading biotech companies. OneSource Specialty Pharma is a pure-play specialty pharmaceutical CDMO. The company focuses on the development and manufacturing of complex pharmaceutical products including biologics, drug-device combinations, sterile injectables, and oral technologies (soft gelatine capsules). It has five manufacturing facilities approved by global regulatory authorities and a dedicated team of over 1,200 professionals. On a consolidated basis, OneSource Specialty Pharma reported net profit of Rs 98.50 crore in Q4 March 2025 as against net loss of Rs 40.17 crore in Q4 March 2024. Net sales surged 482.38% YoY to Rs 425.95 crore in Q4 March 2025.
New Indian Express
4 hours ago
- New Indian Express
Covid poses no threat yet, demand for masks up in Tiruchy
TIRUCHY: Despite only two official Covid-19 cases currently reported in Tiruchy, the demand for masks has seen a cautious resurgence. The health department has advised high-risk individuals, particularly the elderly and those with prior infections, to exercise caution, though mask usage is not mandatory. Currently, a 51-year-old man without comorbidities is receiving treatment for Covid at a private hospital, while a 25-year-old patient is under home isolation. This limited number of active cases has still prompted a return of precautionary behaviour among the public. Retail medical shops, particularly in areas like Thillai Nagar, are reporting a modest increase in mask sales. A pharmacist from the Thillai Nagar outlet noted, 'Normally, we sell about 50 masks a day, mostly for pollution or hospital visits. Now, we're selling double that, primarily to elderly people who had Covid before and feel slightly unwell.' The Tiruchy district Chemists and Druggists Association, said over 800 pharmacies have observed a slight uptick in demand. 'Earlier, selling 100 masks could take a whole month. Now, there's some movement but no real rush,' said President of the association (Tiruchy), P Kirubanandha Moorthy. Three-ply masks are retailing for Rs 5- Rs 10 each, while wholesale packets of 100 three-ply masks are priced at Rs 100. Wholesale traders confirm a sharper trend.
Hans India
4 hours ago
- Hans India
Mobile medical camp at Polakal PHC inspected
Polakal: Dr Raghu, the District Nodal Officer, visited the Ayushman Arogya Mandir under the jurisdiction of the Polakal Primary Health Centre, where a mobile medical camp was being conducted as part of a public health outreach initiative on Tuesday. During his interaction, Dr Raghu stressed the importance of marrying at the legally and biologically appropriate age. He emphasized that the legal age for marriage is 18 years for girls and 21 years for boys. Marrying at an earlier age, particularly during the formative years of adolescence, poses severe health and social consequences, especially for girls. He also highlighted that child marriage is a punishable offense under Indian law. Marrying girls below 18 or boys below 21 is a criminal act, and strict action will be taken against the bridegroom, parents or guardians, wedding participants, priests, and anyone directly or indirectly involved in such marriages. He urged citizens to report any such incidents immediately to the authorities through the Child Helpline – 1098. He reiterated that promoting child marriage can lead to imprisonment of up to two years and a fine of Rs 1 lakh. As part of this awareness campaign, he instructed healthcare personnel to educate families about the legal and health implications of child marriage under the slogan: The program was attended by Dr. Anees Nayak, Medical Officer; Raju Miya, Field Supervisor; Surekha, Social Health Officer; Health Worker Maryamma; ASHA workers; and Projectionist Khalee.
